Dr. Allison Taylor’s work focuses on exploring factors that influence clinical outcomes in patients with hematologic malignancies, esp among those from under-represented backgrounds. Read more of her story as part of our #BlackHistoryMonth spotlight series bit.ly/3uDextZ

Florez Laboratory at Dana-Farber launches International Pregnancy and Lung Cancer Registry. Guest editorial by Narjust Florez, MD, FASCO, Lauren Kiel, Rebekah Kaufman, and Oyepeju Abioye-Akintola.
cancerletter.com/trials-and-tri…

Thank you Coral Olazagasti, MD for speaking up — so heartbreaking to see such a vulnerable population at baseline being further targeted by our legal system. We need to do better

Thanks to all who stopped by our poster! Imaging (tumor size by CT and “stiffness” by MRE), AFP, and tumoral immune cell infiltration could all help determine which patients with resectable HCC are more likely to have a major path response after neoadjuvant IO. #GI24 ASCO

Great presentation by Dr Shah at ASCO #GI24 on the need for gastric cancer screening for immigrants who came from high incidences countries. We need to advocate for more resources to generate high-quality data to support guideline changes in #Stomachcancer #gastric cancer.

Dr. Yin Li presents ESCORT-NEO: Neoadjuvant Camrelizumab + chemo vs chemo alone for esophageal SCC. Promising pCR rates; EFS data still needs to mature. One of the several studies today hinting that SOC may transition to chemo/IO in the neoadjv setting. #GI24 #GIASCO

Dr. Hannah Robinson sheds light on the molecular characteristics of SCC CUP with liver mets. Her findings further support the need for pan-KRAS-directed therapies in GI med onc. #GI24 #GIASCO #DukeFam

CHECKMATE 648 biomarker analysis update provided by Dr. Ken Kato at #GI24 . Prospective studies needed to further understand the utility of several biomarker subgroups #GIASCO